FULL PUBLISHED RESEARCHEarnings and management commentary analysis
Sage PRO · SAMMAANCAP · Quarter ended 30 September 2026 · 18 November 2026
Stance: Watch. Sammaan’s sequential turnaround needs a bridge from recoveries and capital infusion to repeatable earnings per diluted share.
1. Investment decision
Key takeaways
- September AUM rose 5% sequentially to ₹59,188 crore and PAT rose 28% to ₹312 crore.
- AUM remained about 7.5% below the ₹64,004 crore reported a year earlier.
- That combination is consistent with a recovery from the June base while the earlier loan book continues to run off.
Treat Sammaan as a diversified mortgage-led NBFC for peer work. The FY25 annual report records the transition to an RBI NBFC–Investment and Credit Company registration.
AUM (₹ crore)
Disbursements (₹ crore)
2. Financial quality
Key takeaways
- Reported quarterly PBT climbed from ₹326 crore to ₹425 crore.
- Management reported net recoveries of ₹217 crore versus ₹240 crore in June.
- Net recoveries were about 51% of current PBT as a scale comparison.
The net recovery definition mixes recoveries, incremental provisions and other credit costs, so subtracting it mechanically would give an unreliable normalized earnings number.
PAT (₹ crore)
PBT (₹ crore)
3. Business and origination
Key takeaways
- Disbursements climbed from ₹3,875 crore to ₹6,278 crore while the branch network increased from 217 to 245.
- Management is building personal-loan origination and adding gold and MSME products.
- Product growth must be tracked separately because funding needs, expected losses, servicing expenses and capital intensity differ from those of the mortgage portfolio.
Net recoveries (₹ crore)
GNPA (%)
4. Credit risk
Key takeaways
- Reported GNPA eased to 0.15% from 0.21% and NNPA to 0.11% from 0.15% sequentially.
- The issuer also reports performance on sold-down mortgage pools.
- Assess managed and on-balance-sheet credit performance independently, especially after assignment and when assessing the new personal and MSME loan vintages.
NNPA (%)
Net worth before October infusion (₹ crore)
5. Funding and capital
Key takeaways
- September net worth was ₹19,445 crore and capital adequacy 20.0%.
- The ₹906 crore first-tranche warrant proceeds arrived on 30 October after the quarter close.
- They should enter a pro forma capital bridge along with the 8.69 crore shares issued.
Remaining warrant conversion is conditional. Using the higher cash amount with a September share count would overstate book value per share.
Branch network (branches)
Disbursements required by full-year guidance (₹ crore)
6. Peers and valuation
Key takeaways
- Management’s full-year targets imply ₹19,947 crore of H2 disbursements and ₹844 crore of H2 PAT against reported H1 totals of ₹10,153 crore and ₹556 crore.
- The implied H2 disbursement run rate is almost twice the H1 pace.
- Use that bridge to track execution, with a separate check on customer mix and credit quality if origination accelerates.
The 17 November market reference was ₹131.29. A comparable price-to-book valuation requires common equity, period-end ordinary shares and a separate dilution bridge where applicable. An exact target is withheld pending verification of those inputs and consistent peer multiples.
7. Scenarios and monitoring
Key takeaways
- Base monitoring is tied to cohort economics and funding, with company guidance treated as a benchmark.
- Upside requires the growth book to contribute more profit after credit costs and overhead as legacy recoveries decline.
- The downside is volume growth with weaker collections or dilution faster than normalized earnings growth.
Reconcile actual share issuance and the asset and liability maturity ladder before a per-share valuation.
Sensitivity. An annualized 25 basis point change applied to the reported closing AUM is equivalent to approximately ₹148.0 crore before tax. This isolates scale. Realized effects depend on average on-balance-sheet assets, assigned balances, repricing, funding and the timing of income or provisions.
Evidence and limitations
Key takeaways
- The analysis uses results and disclosures for the September 2026 quarter.
- Ratios and financial balances use the issuer’s definitions.
- Figures rounded by the issuer can produce small differences when percentage changes are recalculated.
Scenario assumptions represent operating outcomes. Comparable diluted peer valuation, granular maturity buckets and loan-cohort performance remain diligence items. Market price is an observation from 17 November.
- - - -
Q2 source and financial review · 18 November 2026
Key takeaways
- Management described access to global funding through its strategic shareholder as a priority on the November 14 call.
- Count any benefit only when executed borrowing terms, maturities and hedged costs are disclosed.
- Track cost of funds alongside the new product losses and actual warrant conversions before underwriting returns per share.
Additional earnings and capital analysis
Key takeaways
- The FY27 targets imply an average H2 quarter of about ₹9,974 crore in disbursements and ₹422 crore in PAT.
- Those are about 59% and 35% above the reported September quarter respectively.
- This comparison identifies the acceleration embedded in guidance without treating it as the base case.
The earnings deck also distinguishes ₹59,188 crore of managed AUM from a ₹46,482 crore loan book. The difference is not a complete measure of transferred risk because structured retention and servicing terms matter. A 50-bp annualized funding or credit-cost shock applied illustratively to the closing loan book is about ₹232 crore before tax. That is a scale comparison only, since funding costs apply to liabilities, credit charges apply to eligible exposures, and balances vary during the year.
For valuation, reconcile quarter-end ordinary shares with the dated warrant conversions, the use of proceeds and cash actually available to the parent. Gains on sale, fee income and net recovery effects should be isolated from the underlying spread and operating expense bridge before extrapolating PAT.